Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander F Vom Stein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hematology/Oncology Clinics of North America|July 22, 2025
Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic LeukemiaAlexander F Vom Stein, Lukas P Frenzel
Seminars in Hematology|January 14, 2024
Role of the tumor microenvironment in CLL pathogenesisAlexander F Vom Stein, Michael Hallek, Phuong-Hien Nguyen
Blood|May 22, 2024
Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemiaRichard I Lewis, Alexander F Vom Stein, Michael Hallek
Frontiers in Immunology|June 13, 2025
A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter TransformationAlexander F Vom Stein, Phuong-Hien Nguyen, Elisa Ten Hacken
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory PatientsAnna Maria Frustaci, Alessandra Tedeschi, Alexander F Vom Stein, et al.
Neuro-Oncology|October 15, 2024
The immune landscape in brain metastasisLuca D Schreurs, Alexander F Vom Stein, Stephanie T Jünger, et al.
Journal of Medical Case Reports|October 14, 2025
Fatal outcome of severe serotonin syndrome and acute respiratory distress syndrome after self-poisoning with paroxetine: a case reportSina M Pütz, Christoph Hüser, Oezguer A Onur, et al.
Frontiers in Immunology|April 10, 2023
Non-viral <i>TRAC</i>-knocked-in CD19<sup>KI</sup>CAR-T and gp350<sup>KI</sup>CAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: <i>In vivo</i> cellular dynamics and potencyTobias Braun, Alina Pruene, Milita Darguzyte, et al.
Nature Communications|March 10, 2023
LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1Alexander F Vom Stein, Rocio Rebollido-Rios, Anna Lukas, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|July 22, 2025
Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic LeukemiaAlexander F Vom Stein, Lukas P Frenzel
Seminars in Hematology|January 14, 2024
Role of the tumor microenvironment in CLL pathogenesisAlexander F Vom Stein, Michael Hallek, Phuong-Hien Nguyen
Blood|May 22, 2024
Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemiaRichard I Lewis, Alexander F Vom Stein, Michael Hallek
Frontiers in Immunology|June 13, 2025
A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter TransformationAlexander F Vom Stein, Phuong-Hien Nguyen, Elisa Ten Hacken
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory PatientsAnna Maria Frustaci, Alessandra Tedeschi, Alexander F Vom Stein, et al.
Neuro-Oncology|October 15, 2024
The immune landscape in brain metastasisLuca D Schreurs, Alexander F Vom Stein, Stephanie T Jünger, et al.
Journal of Medical Case Reports|October 14, 2025
Fatal outcome of severe serotonin syndrome and acute respiratory distress syndrome after self-poisoning with paroxetine: a case reportSina M Pütz, Christoph Hüser, Oezguer A Onur, et al.
Frontiers in Immunology|April 10, 2023
Non-viral <i>TRAC</i>-knocked-in CD19<sup>KI</sup>CAR-T and gp350<sup>KI</sup>CAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: <i>In vivo</i> cellular dynamics and potencyTobias Braun, Alina Pruene, Milita Darguzyte, et al.
Nature Communications|March 10, 2023
LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1Alexander F Vom Stein, Rocio Rebollido-Rios, Anna Lukas, et al.
Pageof 1